Pharma To Market Extend Life Science Services Into Asia

Press Release (ePRNews.com) - Brisbane, Australia - Feb 24, 2017 - ​Directors from Pharma To Market Pty Ltd and Ador Consulting Pte Ltd announce that the two companies have joined forces, resulting in the founding of Pharma To Market Pte Ltd, based in Singapore.

Pharma To Market are pleased to announce their expansion into Asia with the opening of an office in Singapore. The company are delighted to appoint Joelle Chia, former owner of Ador Consulting as Co-Director of the Singapore based entity. Joelle brings with her an extensive business network throughout Asia as well as over 12 years’ experience in the pharmaceutical industry. Joelle and her team will provide support for a range of regulatory services in Singapore, Malaysia, Indonesia, Thailand, The Philippines, Vietnam, Taiwan, Hong Kong and South Korea.

“We are proud to open our new office in Singapore and to expand the Pharma To Market footprint into Asia. We consider this important for the growth of Pharma To Market as this region remains a highly attractive yet challenging market for life science companies.”

Johanna Hann, Co-Director

“I am excited to join Pharma To Market and to continue to grow the business in Asia. I look forward to leveraging my network and expertise using the foundations of Pharma To Market’s business practices, reputation and brand,” said Joelle Chia, Co-Director, Pharma To Market Pte Ltd.

Pharma To Market aims to establish a foothold in the region by assisting existing clients enter the region and also by promoting their services to new clients. The company aims to build on the brand and reputation it has successfully developed over the last 8 years.

“We are proud to open our new office in Singapore and to expand the Pharma To Market footprint into Asia. We consider this important for the growth of Pharma To Market as this region remains a highly attractive yet challenging market for life science companies,” said Johanna Hann, Co-Director Pharma To Market.

“We welcome Joelle to Pharma To Market to lead the business in the region. Her vast experience and expertise throughout Asia will be a terrific asset to the business”, said Nick Ward, Co-Director, Pharma To Market.

For more information on Pharma To Market and its services, visit www.pharmatomarket.com.

About Pharma To Market

Pharma To Market is a leading life sciences consulting company with offices in Australia and Singapore. It was founded in 2009 by Co-Directors, Johanna Hann and Nick Ward.

Pharma To Market provides an extensive range of regulatory, market access, compliance, publishing, pharmacovigilance and training services. Pharma To Market assist life science companies to access markets in Australia, New Zealand and now Asia. Pharma To Market’s experience in global regulatory affairs enables them to offer first-hand advice to clients seeking marketing authorisations in all major markets (EU, US, CA, APAC) or assisting clients adapt dossiers for multiple regions. Through partnerships they submit to many agencies globally.

Pharma To Market are one of the only consulting companies within Australia offering eSubmission solutions in addition to regulatory services. Through their partnership with LORENZ Life Sciences, Pharma To Market offer implementation and outsourcing solutions for eCTD, NeeS and paper publishing using LORENZ docuBridge, an industry leading eSubmission publishing tool. Pharma To Market has a dedicated publishing specialist and accredited trainer of docuBridge. They are renowned in the region as the eCTD specialists and regularly run their in-house developed eCTD training courses.

Media Contact:
Nick Ward
Phone: +61 (0)7 3122 9979
Email: nick.ward@pharmatomarket.com

Source : Pharma To Market
Business Info :
Pharma To Market

You may also like this  

DISCLAIMER : If you have any concerns regarding this press release, please contact the Author / Media Contact / Business of this press release. ePRNews is not resposible for the accuracy of the news posted and do not endorse, support any product/services/business mentioned and hereby disclaims any content contained in this press release.

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or form here

Already have an account ? Login

Reset Password

Already have an account ? Login